When the pandemic crisis struck, as a mode of business continuity, many Asia Pacific (APAC) countries accelerated digital transformation creating new opportunities across startup and SME communities. A recent survey by Health-tech company Medtronic revealed that, in around 15 markets of the APAC region, a major percentage of healthcare technology organizations opine that COVID-19 had enabled the development and implementation of innovative ideas, although the positive impact on innovation differed markedly across markets. Even in South-East Asia, telemedicine, online pharmacy, and digital health mobile application gained regional traction solving the long-time concerns about access to a broader spectrum of healthcare services, the need for affordable consultations, quicker appointments, and a significant reduction in the traveling efforts of the patients. Thanks to startups and SMEs for their quick resolutions.
Enhancing Startup and SME success
The pandemic has removed multiple institutional and cultural barriers to the adoption of digital solutions in the healthcare technology setting. Digitization has grown far more rapidly than was previously thought possible and ushered in an acceptance of remote medical products and services, and alternative care models, fostering greater industry innovation. Despite current apprehensions about data protection and regulatory concerns, the healthcare system is uplifting digital healthcare and MedTech capabilities, IoT infrastructure, and cybersecurity strengths to increase workflow efficiency and patient outcomes. Many startups and SMEs are utilising the opportunity by combining pioneering science, data, analytics, and technology to deliver better Personalised healthcare (PHC) at a reduced cost.
This story is from the May 2022 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 2022 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.